Background Nucleotide analogs treatment can reverse liver fibrosis in chronic hepatitis B
(CHB). However, it has limited effect on fibrosis resolution in patients with CHB, particularly …

Ethnopharmacological relevance Antiviral therapy can alleviate liver fibrosis in chronic
hepatitis B, but it has a limited effect on advanced liver fibrosis/cirrhosis. Traditional Chinese …

Background Long-term nucleos (t) ide analogue (NA) treatment can reverse liver fibrosis in
chronic hepatitis B (CHB), but its effect on fibrosis regression remains limited. Biejia …

Abstract Background Hepatitis B virus (HBV) infection is an important etiology for chronic
hepatitis globally, and especially so in China. HBV infection can lead to the development of …

Abstract Background Chronic hepatitis B (CHB) can progress to cirrhosis, hepatocellular
carcinoma (HCC) and ultimately liver-related death. Although oral antiviral therapy for …

Methods Treatment-naïve patients with CHB were randomly treated with ETV alone or
combined with ALHX (ETV+ ALHX) between October 1, 2013 and December 31, 2020 …

Abstract Background and Aims: To evaluate the efficacy of Fuzheng Huayu (FZHY), a
Chinese herbal formula, plus entecavir (ETV) in regression of liver fibrosis in chronic …

Background: Liver cirrhosis is one of the end-stage chronic liver diseases. Individuals with
chronic hepatitis B (CHB) are at an increased risk of developing liver cirrhosis. Practice …

Background: There are currently no FDA-approved biological or chemical drugs for the
treatment of HBV-related liver fibrosis or cirrhosis. Some Chinese patent medicines have …

Objective To evaluate the effect of long-term therapy with entecavir and Fufang Biejia
Ruangan tablet in patients with chronic hepatitis B (CHB)-associated fibrosis and explore …